Mgtrben news
07-19-2010, 09:22 PM
Reuters - A protective gel made using Gilead Sciences Inc's HIV drug tenofovir reduced HIV infections in women by 39 percent over two and a half years -- the first time such an approach has protected against the AIDS virus, South African researchers reported.
Source (http://us.rd.*****.com/dailynews/rss/topstories/*http://news.*****.com/s/nm/20100719/ts_nm/us_aids_gel)
Source (http://us.rd.*****.com/dailynews/rss/topstories/*http://news.*****.com/s/nm/20100719/ts_nm/us_aids_gel)